Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Talis Biomedical Corporation (TLIS)

0.8139   -0.029 (-3.45%) 06-26 19:25
Open: 0.84 Pre. Close: 0.843
High: 0.8998 Low: 0.8
Volume: 1,549,657 Market Cap: 22(M)
Talis Biomedical Corporation operates as a molecular diagnostic company. The company is developing the Talis One system to address limitations of existing point-of-care diagnostic testing technologies for infectious diseases. It also offers Talis One COVID-19 Test System, which focuses on detection of SARS-CoV-2, the virus that causes COVID-19. In addition, it develops Talis One assay kit for respiratory infections, infections related to women's health, and sexually transmitted infections; and other tests for the detection of other respiratory infections, such as a respiratory panel test to detect influenza A, influenza B, and respiratory syncytial virus. Talis Biomedical Corporation was incorporated in 2013 and is headquartered in Menlo Park, California.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.9 - 0.91 0.91 - 0.91
Low: 0.79 - 0.79 0.79 - 0.8
Close: 0.81 - 0.81 0.81 - 0.82

Technical analysis

as of: 2022-06-24 4:43:40 PM
Overall:       
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 1.13     One year: 1.26
Support: Support1: 0.8    Support2: 0.66
Resistance: Resistance1: 0.97    Resistance2: 1.08
Pivot: 0.92
Moving Average: MA(5): 0.84     MA(20): 0.94
MA(100): 1.37     MA(250): 4.35
MACD: MACD(12,26): -0.1     Signal(9): -0.1
Stochastic oscillator: %K(14,3): 12.1     %D(3): 12.6
RSI: RSI(14): 30.5
52-week: High: 12.88  Low: 0.8
Average Vol(K): 3-Month: 185 (K)  10-Days: 322 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ TLIS ] has closed above bottom band by 12.8%. Bollinger Bands are 35.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Sun, 19 Jun 2022
Talelma Lift Irrigation Scheme to be inaugurated today - The Hindu

Wed, 08 Jun 2022
Bio-Rad Laboratories (NYSE:BIO.B) and Talis Biomedical (NASDAQ:TLIS) Financial Survey - Defense World

Sun, 15 May 2022
Talis Biomedical Corporation(TLIS) CEO Rob Kelly on Q12022 Results - Earnings Call Transcript - Seeking Alpha

Wed, 11 May 2022
Talis Biomedical Corporation (TLIS) Q1 2022 Earnings Call Transcript - The Motley Fool

Tue, 10 May 2022
Can Talis Biomedical (NASDAQ:TLIS) Afford To Invest In Growth? - Yahoo Finance

Tue, 26 Apr 2022
Talis Biomedical to Announce First Quarter 2022 Financial Results on May 10, 2022 - Yahoo Finance

Financial Analysis

Price to Book Value: Neutral
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Neutral
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Medical Devices
Shares Out. 0 (M)
Shares Float 26 (M)
% Held by Insiders 9.82e+006 (%)
% Held by Institutions 10.3 (%)
Shares Short 550 (K)
Shares Short P.Month 0 (K)

Stock Financials

EPS -1.9024e+008
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin (%) 0
Operating Margin (%) -2
Return on Assets (ttm) 341.2
Return on Equity (ttm) -51.7
Qtrly Rev. Growth 8.19e+006
Gross Profit (p.s.) -2.92
Sales Per Share 0.28
EBITDA (p.s.) -7.87
Qtrly Earnings Growth -13.8
Operating Cash Flow 0 (M)
Levered Free Cash Flow -171 (M)

Stock Valuations

PE Ratio -0.01
PEG Ratio -0.1
Price to Book value 0
Price to Sales 2.82
Price to Cash Flow 0

Stock Dividends

Dividend 0
Forward Dividend 705060
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
StockChart iOS
stoxline_lite
StoxlineLite iOS
stoxline_pro
StoxlineLite iOS
Option_Calculator
OptionCalc iOS
android_stock_chart
StockChart Android
stoxline_lite
StoxlineLite Android
stoxline_pro
StoxlinePro Android
Option_Calculator
OptionCalc Android
(c) 2006-2022 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.